Filing Details

Accession Number:
0001209191-22-018969
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-15 19:00:39
Reporting Period:
2022-03-14
Accepted Time:
2022-03-15 19:00:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382101 Sutro Biopharma Inc. STRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1309660 J William Newell C/O Sutro Biopharma, Inc.
111 Oyster Point Blvd.
South San Francisco CA 94080
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-14 10,000 $7.75 116,525 No 4 P Indirect By William J. Newell Family Trust DTD 03/15/2019
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By William J. Newell Family Trust DTD 03/15/2019
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,577 Indirect By Newell Family Revocable Trust DTD 08/14/2008
Common Stock 113,460 Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.68 to$7.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of theSecurities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price withinthe range set forth in this footnote.
  2. The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
  3. The securities are held of record by the reporting person as trustee of the Newell Family Revocable Trust DTD 08/14/2008.